Structures of respiratory syncytial virus G antigen bound to broadly neutralizing antibodies

Science Immunology

Volumn 3, Issue 21, 2018, Pages

  Fedechkin, Stanislav O ^a   George, Natasha L ^a   Wolff, Jacob T ^a   Kauvar, Lawrence M ^b   DuBois, Rebecca M ^a  

^a University of California Santa Cruz   (United States)

^b Trellis Bioscience   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CX3CR1; EPITOPE; NEUTRALIZING ANTIBODY; VIRUS ANTIGEN; CX3CR1 PROTEIN, HUMAN; FRACTALKINE; G GLYCOPROTEIN, RESPIRATORY SYNCYTIAL VIRUS; MONOCLONAL ANTIBODY; VIRUS FUSION PROTEIN;

ANTIGEN BINDING; ANTIGEN STRUCTURE; ANTIGENICITY; ARTICLE; BINDING AFFINITY; CHEMOTAXIS; COMPLEX FORMATION; CONTROLLED STUDY; CRYSTAL STRUCTURE; HUMAN RESPIRATORY SYNCYTIAL VIRUS; HUMAN RESPIRATORY SYNCYTIAL VIRUS G; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN TARGETING; SEQUENCE ALIGNMENT; CHEMISTRY; HUMAN; IMMUNOLOGY; TUMOR CELL LINE;

ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIGENS, VIRAL; CELL LINE, TUMOR; CHEMOKINE CX3CL1; CX3C CHEMOKINE RECEPTOR 1; HUMANS; PROTEIN CONFORMATION; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; VIRAL FUSION PROTEINS;

EID: 85052902269     PISSN: None     EISSN: 24709468     Source Type: Journal    
DOI: 10.1126/sciimmunol.aar3534     Document Type: Article

References (41)

1. W. P. Glezen, L. H. Taber, A. L. Frank, J. A. Kasel, Risk of primary infection and reinfection with respiratory syncytial virus. Am. J. Dis. Child. 140, 543–546 (1986).
2. S. Jain, D. J. Williams, S. R. Arnold, K. Ampofo, A. M. Bramley, C. Reed, C. Stockmann, E. J. Anderson, C. G. Grijalva, W. H. Self, Y. Zhu, A. Patel, W. Hymas, J. D. Chappell, R. A. Kaufman, J. H. Kan, D. Dansie, N. Lenny, D. R. Hillyard, L. M. Haynes, M. Levine, S. Lindstrom, J. M. Winchell, J. M. Katz, D. Erdman, E. Schneider, L. A. Hicks, R. G. Wunderink, K. M. Edwards, A. T. Pavia, J. A. McCullers, L. Finelli; CDC EPIC Study Team, Community-acquired pneumonia requiring hospitalization among U.S. children. N. Engl. J. Med. 372, 835–845 (2015).
3. T. Shi, D. A. McAllister, K. L. O’Brien, E. A. F. Simoes, S. A. Madhi, B. D. Gessner, F. P. Polack, E. Balsells, S. Acacio, C. Aguayo, I. Alassani, A. Ali, M. Antonio, S. Awasthi, J. O. Awori, E. Azziz-Baumgartner, H. C. Baggett, V. L. Baillie, A. Balmaseda, A. Barahona, S. Basnet, Q. Bassat, W. Basualdo, G. Bigogo, L. Bont, R. F. Breiman, W. A. Brooks, S. Broor, N. Bruce, D. Bruden, P. Buchy, S. Campbell, P. Carosone-Link, M. Chadha, J. Chipeta, M. Chou, W. Clara, C. Cohen, E. de Cuellar, D. A. Dang, B. Dash-Yandag, M. Deloria-Knoll, M. Dherani, T. Eap, B. E. Ebruke, M. Echavarria, C. C. de Freitas Lázaro Emediato, R. A. Fasce, D. R. Feikin, L. Feng, A. Gentile, A. Gordon, D. Goswami, S. Goyet, M. Groome, N. Halasa, S. Hirve, N. Homaira, S. R. C. Howie, J. Jara, I. Jr oundi, C. B. Kartasasmita, N. Khuri-Bulos, K. L. Kotloff, A. Krishnan, R. Libster, O. Lopez, M. G. Lucero, F. Lucion, S. P. Lupisan, D. N. Marcone, J. P. McCracken, M. Mejia, J. C. Moisi, J. M. Montgomery, D. P. Moore, C. Moraleda, J. Moyes, P. Munywoki, K. Mutyara, M. P. Nicol, D. J. Nokes, P. Nymadawa, M. T. da Costa Oliveira, H. Oshitani, N. Pandey, G. Paranhos-Baccalà, L. N. Phillips, V. S. Picot, M. Rahman, M. Rakoto-Andrianarivelo, Z. A. Rasmussen, B. A. Rath, A. Robinson, C. Romero, G. Russomando, V. Salimi, P. Sawatwong, N. Scheltema, B. Schweiger, J. A. G. Scott, P. Seidenberg, K. Shen, R. Singleton, V. Sotomayor, T. A. Strand, A. Sutanto, M. Sylla, M. D. Tapia, S. Thamthitiwat, E. D. Thomas, R. Tokarz, C. Turner, M. Venter, S. Waicharoen, J. Wang, W. Watthanaworawit, L. M. Yoshida, H. Yu, H. J. Zar, H. Campbell, H. Nair; RSV Global Epidemiology Network, Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: A systematic review and modelling study. Lancet 390, 946–958 (2017).
4. C. B. Hall, G. A. Weinberg, M. K. Iwane, A. K. Blumkin, K. M. Edwards, M. A. Staat, P. Auinger, M. R. Griffin, K. A. Poehling, D. Erdman, C. G. Grijalva, Y. Zhu, P. Szilagyi, The burden of respiratory syncytial virus infection in young children. N. Engl. J. Med. 360, 588–598 (2009).
5. R. Lozano, M. Naghavi, K. Foreman, S. Lim, K. Shibuya, V. Aboyans, J. Abraham, T. Adair, R. Aggarwal, S. Y. Ahn, M. Alvarado, H. R. Anderson, L. M. Anderson, K. G. Andrews, C. Atkinson, L. M. Baddour, S. Barker-Collo, D. H. Bartels, M. L. Bell, E. J. Benjamin, D. Bennett, K. Bhalla, B. Bikbov, A. Bin Abdulhak, G. Birbeck, F. Blyth, I. Bolliger, S. Boufous, C. Bucello, M. Burch, P. Burney, J. Carapetis, H. Chen, D. Chou, S. S. Chugh, L. E. Coffeng, S. D. Colan, S. Colquhoun, K. E. Colson, J. Condon, M. D. Connor, L. T. Cooper, M. Corriere, M. Cortinovis, K. C. de Vaccaro, W. Couser, B. C. Cowie, M. H. Criqui, M. Cross, K. C. Dabhadkar, N. Dahodwala, D. De Leo, L. Degenhardt, A. Delossantos, J. Denenberg, D. C. Des Jarlais, S. D. Dharmaratne, E. R. Dorsey, T. Driscoll, H. Duber, B. Ebel, P. J. Erwin, P. Espindola, M. Ezzati, V. Feigin, A. D. Flaxman, M. H. Forouzanfar, F. G. Fowkes, R. Franklin, M. Fransen, M. K. Freeman, S. E. Gabriel, E. Gakidou, F. Gaspari, R. F. Gillum, D. Gonzalez-Medina, Y. A. Halasa, D. Haring, J. E. Harrison, R. Havmoeller, R. J. Hay, B. Hoen, P. J. Hotez, D. Hoy, K. H. Jacobsen, S. L. James, R. Jasrasaria, S. Jayaraman, N. Johns, G. Karthikeyan, N. Kassebaum, A. Keren, J.-P. Khoo, L. M. Knowlton, O. Kobusingye, A. Koranteng, R. Krishnamurthi, M. Lipnick, S. E. Lipshultz, S. L. Ohno, J. Mabweijano, M. F. MacIntyre, L. Mallinger, L. March, G. B. Marks, R. Marks, A. Matsumori, R. Matzopoulos, B. M. Mayosi, J. H. McAnulty, M. M. McDermott, J. McGrath, G. A. Mensah, T. R. Merriman, C. Michaud, M. Miller, T. R. Miller, C. Mock, A. O. Mocumbi, A. A. Mokdad, A. Moran, K. Mulholland, M. N. Nair, L. Naldi, K. M. Narayan, K. Nasseri, P. Norman, M. O’Donnell, S. B. Omer, K. Ortblad, R. Osborne, D. Ozgediz, B. Pahari, J. D. Pandian, A. P. Rivero, R. P. Padilla, F. Perez-Ruiz, N. Perico, D. Phillips, K. Pierce, C. A. Pope III, E. Porrini, F. Pourmalek, M. Raju, D. Ranganathan, J. T. Rehm, D. B. Rein, G. Remuzzi, F. P. Rivara, T. Roberts, F. R. De León, L. C. Rosenfeld, L. Rushton, R. L. Sacco, J. A. Salomon, U. Sampson, E. Sanman, D. C. Schwebel, M. Segui-Gomez, D. S. Shepard, D. Singh, J. Singleton, K. Sliwa, E. Smith, A. Steer, J. A. Taylor, B. Thomas, I. M. Tleyjeh, J. A. Towbin, T. Truelsen, E. A. Undurraga, N. Venketasubramanian, L. Vijayakumar, T. Vos, G. R. Wagner, M. Wang, W. Wang, K. Watt, M. A. Weinstock, R. Weintraub, J. D. Wilkinson, A. D. Woolf, S. Wulf, P.-H. Yeh, P. Yip, A. Zabetian, Z. J. Zheng, A. D. Lopez, C. J. Murray, M. A. AlMazroa, Z. A. Memish, Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2095–2128 (2012).
6. The IMpact-RSV Study Group, Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 102, 531–537 (1998).
7. C. Capella, S. Chaiwatpongsakorn, E. Gorrell, Z. A. Risch, F. Ye, S. E. Mertz, S. M. Johnson, M. Moore-Clingenpeel, O. Ramilo, A. Mejias, M. E. Peeples, Prefusion F, postfusion F, G antibodies and disease severity in infants and young children with acute respiratory syncytial virus infection. J Infect Dis 216, 1398–1406 (2017).
8. J. S. McLellan, M. Chen, M. G. Joyce, M. Sastry, G. B. E. Stewart-Jones, Y. Yang, B. Zhang, L. Chen, S. Srivatsan, A. Zheng, T. Zhou, K. W. Graepel, A. Kumar, S. Moin, J. C. Boyington, G.-Y. Chuang, C. Soto, U. Baxa, A. Q. Bakker, H. Spits, T. Beaumont, Z. Zheng, N. Xia, S.-Y. Ko, J.-P. Todd, S. Rao, B. S. Graham, P. D. Kwong, Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus. Science 342, 592–598 (2013).
9. R. A. Tripp, U. F. Power, P. J. M. Openshaw, L. M. Kauvar, Respiratory syncytial virus (RSV): Targeting the G protein provides a new approach for an old problem. J. Virol. 92, e01302-17, (2018).
10. S. M. Johnson, B. A. McNally, I. Ioannidis, E. Flano, M. N. Teng, A. G. Oomens, E. E. Walsh, M. E. Peeples, Respiratory syncytial virus uses CX3CR1 as a receptor on primary human airway epithelial cultures. PLOS Pathog. 11, e1005318 (2015).
11. T. Chirkova, S. Lin, A. G. P. Oomens, K. A. Gaston, S. Boyoglu-Barnum, J. Meng, C. C. Stobart, C. U. Cotton, T. V. Hartert, M. L. Moore, A. G. Ziady, L. J. Anderson, CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells. J. Gen. Virol. 96, 2543–2556 (2015).
12. K.-I. Jeong, P. A. Piepenhagen, M. Kishko, J. M. DiNapoli, R. P. Groppo, L. Zhang, J. Almond, H. Kleanthous, S. Delagrave, M. Parrington, CX3CR1 is expressed in differentiated human ciliated airway cells and co-localizes with respiratory syncytial virus on cilia in a G protein-dependent manner. PLOS ONE 10, e0130517 (2015).
13. R. A. Tripp, L. P. Jones, L. M. Haynes, H. Zheng, P. M. Murphy, L. J. Anderson, CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein. Nat. Immunol. 2, 732–738 (2001).
14. D. A. Hendricks, K. Baradaran, K. McIntosh, J. L. Patterson, Appearance of a soluble form of the G protein of respiratory syncytial virus in fluids of infected cells. J. Gen. Virol. 68 (Pt. 6), 1705–1714 (1987).
15. D. A. Hendricks, K. McIntosh, J. L. Patterson, Further characterization of the soluble form of the G glycoprotein of respiratory syncytial virus. J. Virol. 62, 2228–2233 (1988).
16. R. Arnold, B. König, H. Werchau, W. König, Respiratory syncytial virus deficient in soluble G protein induced an increased proinflammatory response in human lung epithelial cells. Virology 330, 384–397 (2004).
17. + T cell responses. J. Immunol. 176, 1600–1608 (2006).
18. L. M. Haynes, L. P. Jones, A. Barskey, L. J. Anderson, R. A. Tripp, Enhanced disease and pulmonary eosinophilia associated with formalin-inactivated respiratory syncytial virus vaccination are linked to G glycoprotein CX3C-CX3CR1 interaction and expression of substance P. J. Virol. 77, 9831–9844 (2003).
19. M. N. Teng, S. S. Whitehead, P. L. Collins, Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo. Virology 289, 283–296 (2001).
20. S. Boyoglu-Barnum, S. O. Todd, J. Meng, T. R. Barnum, T. Chirkova, L. M. Haynes, S. J. Jadhao, R. A. Tripp, A. G. Oomens, M. L. Moore, L. J. Anderson, Mutating the CX3C motif in the G protein should make a live respiratory syncytial virus vaccine safer and more effective. J. Virol. 91, e02059-16 (2017).
21. L. J. Anderson, J. C. Hierholzer, Y. O. Stone, C. Tsou, B. F. Fernie, Identification of epitopes on respiratory syncytial virus proteins by competitive binding immunoassay. J. Clin. Microbiol. 23, 475–480 (1986).
22. E. J. Collarini, F. E.-H. Lee, O. Foord, M. Park, G. Sperinde, H. Wu, W. D. Harriman, S. F. Carroll, S. L. Ellsworth, L. J. Anderson, R. A. Tripp, E. E. Walsh, B. A. Keyt, L. M. Kauvar, Potent high-affinity antibodies for treatment and prophylaxis of respiratory syncytial virus derived from B cells of infected patients. J. Immunol. 183, 6338–6345 (2009).
23. H.-J. Lee, J.-Y. Lee, M.-H. Park, J.-Y. Kim, J. Chang, Monoclonal antibody against G glycoprotein increases respiratory syncytial virus clearance in vivo and prevents vaccine-enhanced diseases. PLOS ONE 12, e0169139 (2017).
24. B. Cortjens, E. Yasuda, X. Yu, K. Wagner, Y. B. Claassen, A. Q. Bakker, J. B. M. van Woensel, T. Beaumont, Broadly reactive anti-respiratory syncytial virus G antibodies from exposed individuals effectively inhibit infection of primary airway epithelial cells. J. Virol. 91, e02357-16 (2017).
25. S. Boyoglu-Barnum, S. O. Todd, T. Chirkova, T. R. Barnum, K. A. Gaston, L. M. Haynes, R. A. Tripp, M. L. Moore, L. J. Anderson, An anti-G protein monoclonal antibody treats RSV disease more effectively than an anti-F monoclonal antibody in BALB/c mice. Virology 483, 117–125 (2015).
26. H. Caidi, J. L. Harcourt, R. A. Tripp, L. J. Anderson, L. M. Haynes, Combination therapy using monoclonal antibodies against respiratory syncytial virus (RSV) G glycoprotein protects from RSV disease in BALB/c mice. PLOS ONE 7, e51485 (2012).
27. L. M. Haynes, H. Caidi, G. U. Radu, C. Miao, J. L. Harcourt, R. A. Tripp, L. J. Anderson, Therapeutic monoclonal antibody treatment targeting respiratory syncytial virus (RSV) G protein mediates viral clearance and reduces the pathogenesis of RSV infection in BALB/c mice. J Infect Dis 200, 439–447 (2009).
28. G. U. Radu, H. Caidi, C. Miao, R. A. Tripp, L. J. Anderson, L. M. Haynes, Prophylactic treatment with a G glycoprotein monoclonal antibody reduces pulmonary inflammation in respiratory syncytial virus (RSV)-challenged naïve and formalin-inactivated RSV-immunized BALB/c mice. J. Virol. 84, 9632–9636 (2010).
29. L. M. Kauvar, E. J. Collarini, B. Keyt, O. Foord, Anti-RSV G protein antibodies, Patent number US 8273354 (2010).
30. M. Sugawara, J. Czaplicki, J. Ferrage, A. Milon, J.-F. Haeuw, U. F. Power, N. Corvaïa, T. Nguyen, A. Beck, Structure–antigenicity relationship studies of the central conserved region of human respiratory syncytial virus protein G. J. Pept. Res. 60, 271–282 (2002).
31. J. F. Doreleijers, J. P. M. Langedijk, K. Hård, R. Boelens, J. A. C. Rullmann, W. M. Schaaper, J. T. van Oirschot, R. Kaptein, Solution structure of the immunodominant region of protein G of bovine respiratory syncytial virus. Biochemistry 35, 14684–14688 (1996).
32. B. Shields, J. Mills, R. Ghildyal, P. Gooley, J. Meanger, Multiple heparin binding domains of respiratory syncytial virus G mediate binding to mammalian cells. Arch. Virol. 148, 1987–2003 (2003).
33. I. Kufareva, C. L. Salanga, T. M. Handel, Chemokine and chemokine receptor structure and interactions: Implications for therapeutic strategies. Immunol. Cell Biol. 93, 372–383 (2015).
34. S. S. Lieberman-Blum, H. B. Fung, J. C. Bandres, Maraviroc: A CCR5-receptor antagonist for the treatment of HIV-1 infection. Clin. Ther. 30, 1228–1250 (2008).
35. S. Fuentes, E. M. Coyle, J. Beeler, H. Golding, S. Khurana, Antigenic fingerprinting following primary RSV infection in young children identifies novel antigenic sites and reveals unlinked evolution of human antibody repertoires to fusion and attachment glycoproteins. PLOS Pathog. 12, e1005554 (2016).
36. T. G. G. Battye, L. Kontogiannis, O. Johnson, H. R. Powell, A. G. W. Leslie, iMOSFLM: A new graphical interface for diffraction-image processing with MOSFLM. Acta Crystallogr. D Biol. Crystallogr. 67, 271–281 (2011).
37. P. R. Evans, G. N. Murshudov, How good are my data and what is the resolution? Acta Crystallogr. D Biol. Crystallogr. 69, 1204–1214 (2013).
38. A. J. McCoy, R. W. Grosse-Kunstleve, P. D. Adams, M. D. Winn, L. C. Storoni, R. J. Read, Phaser crystallographic software. J. Appl. Crystallogr. 40, 658–674 (2007).
39. P. D. Adams, P. V. Afonine, G. Bunkóczi, V. B. Chen, I. W. Davis, N. Echols, J. J. Headd, L.-W. Hung, G. J. Kapral, R. W. Grosse-Kunstleve, A. J. McCoy, N. W. Moriarty, R. Oeffner, R. J. Read, D. C. Richardson, J. S. Richardson, T. C. Terwilliger, P. H. Zwart, PHENIX: A comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213–221 (2010).
40. P. Emsley, K. Cowtan, Coot: Model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126–2132 (2004).
41. Z. Otwinowski, W. Minor, Processing of X-ray diffraction data collected in oscillation mode, in Methods in Enzymology, C. W. Carter Jr., Ed. (Academic Press, 1997), vol. 276, pp. 307–326.